ArticleJournal of gastric cancer2022

Long-Term Survival Outcomes of Elderly Patients Treated With S-1 or Capecitabine Plus Oxaliplatin for Stage II or III Gastric Cancer: A Multicenter Cohort Study.

Seohee Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.